Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer.
about
Neoadjuvant therapy for pancreas cancer: past lessons and future therapiesSystemic therapies for pancreatic cancer--the role of pharmacogeneticsSingle nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivoInsulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome.Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer.Systemic therapy for metastatic pancreatic adenocarcinoma.DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus.DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancerDNA mismatch repair gene polymorphisms affect survival in pancreatic cancer.A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival.Verification of TREX1 as a promising indicator of judging the prognosis of osteosarcoma.Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer.The activity of the lipophilic nucleoside derivatives elacytarabine and CP-4126 in a panel of tumor cell lines resistant to nucleoside analogues.Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy.Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients.Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer.Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy.Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies.The significance of Exonuclease 1 K589E polymorphism on hepatocellular carcinoma susceptibility in the Turkish population: a case-control study.A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients
P2860
Q27004292-FB22989A-32CA-4FD8-823C-E07CB9186B1EQ27021716-654778A7-43BE-4958-BB2E-E7219121C941Q33575608-A56E0576-B920-4214-8F4B-5A397260FA9DQ33838679-AAB19A3E-81C7-42D0-9422-A5977694ED3EQ33927370-78E10A33-B8A3-4A9D-84A7-F9C7033C5227Q34023117-97576EF4-E63B-4407-A031-037598BCA9AFQ34474400-85CB3C6A-51D1-4EA9-8FDF-46701BDDABDDQ35048269-A45BA1DB-2B07-4B04-BDA5-E72CF8E72FC3Q35076238-3FE8C709-9C30-4F6B-9AC0-0F781AEC8836Q35221075-5E7EB645-BAB0-4466-8829-F2DBA7EC8F61Q35231578-81CC159F-E79B-445A-8743-E5A1FB324636Q35584339-74652FBD-0E60-4D15-9CD3-7B500B6DB512Q36600132-703AE720-48D3-4007-8356-9144BFC3F0D1Q37436670-7FC2B89B-BCDD-4EAF-881D-2A562A32E916Q37495918-B12A2B4C-934C-4533-92C3-58551CEE35E9Q37653931-BF45E090-10B2-4CE5-A141-761AE18BEB0CQ39693736-EABFA98B-F7E1-4A3A-A722-F0B68F5F630BQ40341051-8CE54ECA-9BED-44D8-8D35-BABFCA1C07ACQ40633085-84D9931F-0DB3-456C-89AB-7DC1CD278486Q42373192-E9A53E71-FA93-4F4D-8AC6-07AF71860ABEQ42725709-F2C420DC-FF22-4215-9085-1854317CC2FEQ47102782-2C32421B-2397-4D20-BC20-10C7A4A59EA8Q53195871-B1067915-18BE-47D0-8BC2-4CF05A333F27Q54103392-B58A2D8B-7129-4DAA-8DAA-0458B704939FQ57177355-4C6BBE54-AA98-4253-9B03-D646C465EA8B
P2860
Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Significant associations of mi ...... outcome of pancreatic cancer.
@en
Significant associations of mi ...... outcome of pancreatic cancer.
@nl
type
label
Significant associations of mi ...... outcome of pancreatic cancer.
@en
Significant associations of mi ...... outcome of pancreatic cancer.
@nl
prefLabel
Significant associations of mi ...... outcome of pancreatic cancer.
@en
Significant associations of mi ...... outcome of pancreatic cancer.
@nl
P2093
P2860
P356
P1476
Significant associations of mi ...... outcome of pancreatic cancer.
@en
P2093
Donghui Li
Douglas B Evans
Huamin Wang
James L Abbruzzese
Kenneth R Hess
Xiaoqun Dong
P2860
P304
P356
10.1200/JCO.2008.20.1111
P407
P577
2009-02-23T00:00:00Z